Sanofi India Limited today announced the appointment of N. Rajaram as Country Head and General Manager - Pharmaceutical Operations, India with effect from April 2014. He reports to Dr. Shailesh Ayyangar, Vice President - South Asia, Sanofi and Managing Director - Sanofi India Limited.
Rajaram joins Sanofi India Limited with diverse experience of over two decades in FMCG industry with Hindustan Unilever, and in the telecom industry with Airtel. He will be responsible for driving the Company’s ambitious growth plans in the Pharmaceutical and Consumer Healthcare segments.
Speaking on the appointment and new organisation structure, Dr. Shailesh Ayyangar, Vice President - South Asia, Sanofi and Managing Director - Sanofi India Limited said, “The healthcare industry in India is on the threshold of major transformation - as we address the problem of increasing access to quality healthcare and medicines to our large population. Rajaram’s induction reinforces Sanofi’s commitment to deliver innovative solutions to access issues. His vast experience and consumer insights will help drive Sanofi’s growth strategy in India.”
Commenting on his new role, N. Rajaram, Country Head and General Manager - Pharmaceutical Operations – Sanofi India Limited said, “This is a very exciting opportunity for me. The pharmaceutical
industry is witnessing a rapid change in different aspects such as innovative healthcare delivery and patient care. The prospect of playing a responsible role in making a difference in the lives of people is very exciting and fulfilling.”
Rajaram holds a bachelor’s degree in Electrical and Electronic Engineering from the prestigious Birla Institute of Technology & Science, Pilani, India and an MBA in International Business from the Indian Institute of Foreign Trade, New Delhi.
About Sanofi:
Sanofi, a global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients’ needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets, animal health and the new Genzyme. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY). In India, Sanofi is present since 1956.
Rajaram joins Sanofi India Limited with diverse experience of over two decades in FMCG industry with Hindustan Unilever, and in the telecom industry with Airtel. He will be responsible for driving the Company’s ambitious growth plans in the Pharmaceutical and Consumer Healthcare segments.
Speaking on the appointment and new organisation structure, Dr. Shailesh Ayyangar, Vice President - South Asia, Sanofi and Managing Director - Sanofi India Limited said, “The healthcare industry in India is on the threshold of major transformation - as we address the problem of increasing access to quality healthcare and medicines to our large population. Rajaram’s induction reinforces Sanofi’s commitment to deliver innovative solutions to access issues. His vast experience and consumer insights will help drive Sanofi’s growth strategy in India.”
Commenting on his new role, N. Rajaram, Country Head and General Manager - Pharmaceutical Operations – Sanofi India Limited said, “This is a very exciting opportunity for me. The pharmaceutical
industry is witnessing a rapid change in different aspects such as innovative healthcare delivery and patient care. The prospect of playing a responsible role in making a difference in the lives of people is very exciting and fulfilling.”
Rajaram holds a bachelor’s degree in Electrical and Electronic Engineering from the prestigious Birla Institute of Technology & Science, Pilani, India and an MBA in International Business from the Indian Institute of Foreign Trade, New Delhi.
About Sanofi:
Sanofi, a global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients’ needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets, animal health and the new Genzyme. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY). In India, Sanofi is present since 1956.